Drug interactions and duplicate prescriptions among ambulatory cancer patients.
Recruiting
- Conditions
- drug interaction, ambulatory cancer patients, OTC drugs.
- Registration Number
- NL-OMON22605
- Lead Sponsor
- VU university medical center, Zaans Medical Center
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 300
Inclusion Criteria
All patients with solid and hematologic malignancy currently using systemic anti-cancer drugs are asked to participate in the study.
Exclusion Criteria
1. Unable to fill out questionnaires;
2. The use of trial medication;
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The aim of the present study is to gain more insight into the prevalence of interactions and duplicate prescriptions among cancer patients being treated in the outpatient day care departments for oncology and hemato-oncology. This will be the first study into the prevalence of drug interactions with OTC-drugs in cancer patients.
- Secondary Outcome Measures
Name Time Method Possible risk factors for the occurrence of these drug-related problems will also be studied.